Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02631044
Title Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell Non-Hodgkin Lymphoma (TRANSCEND-NHL-001)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Juno Therapeutics, a Subsidiary of Celgene
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.